FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147672862> ?p ?o ?g. }

• W3147672862 abstract "Thalidomide is currently used for treating erythema nodosum leprosum, multiple myeloma, angiogenesis, rheumatoid arthritis, graft-versus-host disease, among others. Thalidomide effects are related to its capacity to inhibit the proinflammatory cytokine tumor necrosis factor-α (TNF-α) and, in consequence, causes immunomodulation on other cytokines. During the establishment of some diseases the balance between proinflammatory and antiinflammatory cytokines is disrupted, promoting a pathological state; thus, elevated levels of proinflammatory cytokines mediate several deleterious processes such as inflammation, necrosis, apoptosis and fibrosis. These events are present in acute and chronic degenerative liver diseases such as hepatitis, cholangitis, cirrhosis and hepatocellular carcinoma (HCC). Then, the immunomodulation on cytokines by drugs seems to be a pharmacological target to ameliorate liver damage and cirrhosis. In fact, there are not sufficient drugs for relief or cure of cirrhosis currently; some of these * Address: Calle Dr. Eliseo Ramirez Ulloa no. 400, Colonia Doctores, Pachuca, Hidalgo, Mexico C.P. 42090 Telephone: (52) +7717172000 ext. 4510 and 4512 E-mail: efernan@uaeh.edu.mx and tomedyfm@hotmail.com The exclusive license for this PDF is limited to personal website use only. No part of this digital document may be reproduced, stored in a retrieval system or transmitted commercially in any form or by any means. The publisher has taken reasonable care in the preparation of this digital document, but makes no expressed or implied warranty of any kind and assumes no responsibility for any errors or omissions. No liability is assumed for incidental or consequential damages in connection with or arising out of information contained herein. This digital document is sold with the clear understanding that the publisher is not engaged in rendering legal, medical or any other professional services. Eduardo Fernandez-Martinez 2 few are expensive, unstable and palliative or may cause side effects. Novel thalidomide analogs have been synthesized with improved stability and potency as TNF-α inhibitory and immunomodulatory agents, besides low or none teratogenicity. Experimental assessment of thalidomide and its analogs in animal models of liver injury have afforded very hopeful outcomes. Thalidomide and two analogs have evidenced anticholestatic, antinecrotic and antifibrotic activities in bile duct ligation-induced biliary cirrhosis. Another analog protected D-galactosamine/endotoxin-treated mice from liver damage. Thalidomide ameliorated the alcoholic hepatic injury and prevented necrosis, cholestasis and fibrosis induced by CCl4 in rats. Moreover, this drug salvaged from lethal hepatic necroinflammation and accelerated the recovery from established thioacetamideprovoked cirrhosis in rats. The antiinflammatory, antinecrotic and antifibrotic effects elicited by thalidomide and its analogs are mainly mediated by the inhibition on TNF- through two different routes, as well as the down-regulation of nuclear factor-B (NFB) signaling pathway and by diminishing adhesion molecules to prevent the progression of liver fibrosis and cirrhosis. Furthermore, thalidomide showed beneficial effects on HCC by decreasing angiogenesis and metastasis in murine models; therefore, diverse clinical phase I/II studies were carried out to evaluate its antitumoral or disease control outcomes. However, thalidomide as a single drug therapy yields very modest benefits, although in most cases this is well tolerated and offers disease stabilization. Different doses and the combination with other chemotherapeutic agents appear to enhance therapeutic effects; the assessment of the new thalidomide analogs in next clinical trials of HCC healing is strongly suggested. Thalidomide and its analogs may be a feasible option for the treatment of liver diseases and cirrhosis." @default.
• W3147672862 created "2021-04-13" @default.
• W3147672862 creator A5066062900 @default.
• W3147672862 date "2011-01-01" @default.
• W3147672862 modified "2023-09-26" @default.
• W3147672862 title "Thalidomide and its Analogs: A Potential Immunomodulatory Alternative for Treating Liver Diseases and Cirrhosis" @default.
• W3147672862 cites W10317444 @default.
• W3147672862 cites W1572538762 @default.
• W3147672862 cites W1603929148 @default.
• W3147672862 cites W1764517271 @default.
• W3147672862 cites W1840442667 @default.
• W3147672862 cites W1928430680 @default.
• W3147672862 cites W193903826 @default.
• W3147672862 cites W1962242957 @default.
• W3147672862 cites W1965938315 @default.
• W3147672862 cites W1966086522 @default.
• W3147672862 cites W1968789521 @default.
• W3147672862 cites W1974520996 @default.
• W3147672862 cites W1975198339 @default.
• W3147672862 cites W1975655020 @default.
• W3147672862 cites W1978959928 @default.
• W3147672862 cites W1980039004 @default.
• W3147672862 cites W1982278353 @default.
• W3147672862 cites W1985147506 @default.
• W3147672862 cites W1986021912 @default.
• W3147672862 cites W1986847430 @default.
• W3147672862 cites W1986984580 @default.
• W3147672862 cites W1987525830 @default.
• W3147672862 cites W1991000010 @default.
• W3147672862 cites W1996826841 @default.
• W3147672862 cites W1997037000 @default.
• W3147672862 cites W1998478088 @default.
• W3147672862 cites W1999091338 @default.
• W3147672862 cites W2001894153 @default.
• W3147672862 cites W2004864382 @default.
• W3147672862 cites W2005317484 @default.
• W3147672862 cites W2007882007 @default.
• W3147672862 cites W2009106222 @default.
• W3147672862 cites W2013829288 @default.
• W3147672862 cites W2014085694 @default.
• W3147672862 cites W2015422069 @default.
• W3147672862 cites W2015658221 @default.
• W3147672862 cites W2015906681 @default.
• W3147672862 cites W2016529921 @default.
• W3147672862 cites W201732871 @default.
• W3147672862 cites W2017377634 @default.
• W3147672862 cites W2022119530 @default.
• W3147672862 cites W2027774332 @default.
• W3147672862 cites W2031682782 @default.
• W3147672862 cites W2031799817 @default.
• W3147672862 cites W2034031119 @default.
• W3147672862 cites W2035144483 @default.
• W3147672862 cites W2041448864 @default.
• W3147672862 cites W2042535856 @default.
• W3147672862 cites W2043683908 @default.
• W3147672862 cites W2046214686 @default.
• W3147672862 cites W2047598922 @default.
• W3147672862 cites W2049714321 @default.
• W3147672862 cites W2051476082 @default.
• W3147672862 cites W2052762102 @default.
• W3147672862 cites W2054486856 @default.
• W3147672862 cites W2055087223 @default.
• W3147672862 cites W2055174673 @default.
• W3147672862 cites W2055375225 @default.
• W3147672862 cites W2057032766 @default.
• W3147672862 cites W2062373115 @default.
• W3147672862 cites W2063518134 @default.
• W3147672862 cites W2064815099 @default.
• W3147672862 cites W2068655098 @default.
• W3147672862 cites W2073402776 @default.
• W3147672862 cites W2075017432 @default.
• W3147672862 cites W2075192636 @default.
• W3147672862 cites W2075325404 @default.
• W3147672862 cites W2076831987 @default.
• W3147672862 cites W2080769255 @default.
• W3147672862 cites W2083469788 @default.
• W3147672862 cites W2084633989 @default.
• W3147672862 cites W2085122621 @default.
• W3147672862 cites W2087718406 @default.
• W3147672862 cites W2089568581 @default.
• W3147672862 cites W2093915140 @default.
• W3147672862 cites W2095412079 @default.
• W3147672862 cites W2095559060 @default.
• W3147672862 cites W2096463787 @default.
• W3147672862 cites W2096896782 @default.
• W3147672862 cites W2097860477 @default.
• W3147672862 cites W2102444682 @default.
• W3147672862 cites W2103289907 @default.
• W3147672862 cites W2105070448 @default.
• W3147672862 cites W2105109537 @default.
• W3147672862 cites W2105340780 @default.
• W3147672862 cites W2105930239 @default.
• W3147672862 cites W2108773352 @default.
• W3147672862 cites W2109039477 @default.
• W3147672862 cites W2111567512 @default.
• W3147672862 cites W2111796536 @default.
• W3147672862 cites W2116779954 @default.
• W3147672862 cites W2118462346 @default.
• W3147672862 cites W2121256788 @default.
• W3147672862 cites W2121270019 @default.

• next